CBIA (CBIA) Stock Price & Analysis
CBIA (CBIA) rose 0.00% to USD 0 as of June 10, 2026 at 12:05 UTC, according to Nexqual real-time market data.
CBIA last closed at USD 0; the session ranged USD 0–0 on volume of 5,140,999 shares. Market capitalization is $278,772, with a 52-week range of USD 0–0 (PNK). Source: Nexqual, June 10, 2026 at 12:05 UTC.
Key Statistics (as of June 10, 2026 at 12:05 UTC)
| Price | USD 0 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0 |
| Open | USD 0 |
| Day Range | USD 0 – 0 |
| 52-Week Range | USD 0 – 0 |
| Volume | 5,140,999 shares |
| Market Cap | $278,772 |
| Exchange | PNK |
Technical Analysis (CBIA)
Nexqual's technical model rates CBIA "STRONG SELL" based on 0 bullish and 5 bearish signals across 124 daily candles, as of June 10, 2026 at 12:05 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 100 (overbought) |
| vs SMA50 | Below (USD 0) |
| MACD | 0 (negative) |
Analyst Ratings (CBIA)
Wall Street analysts rate CBIA "None", per Nexqual as of June 10, 2026 at 12:05 UTC.
| Consensus Rating | None |
|---|
Earnings (CBIA)
Source: Nexqual, June 10, 2026 at 12:05 UTC.
Financials & Fundamentals (CBIA)
| Gross Margin | +0.00% |
|---|---|
| Operating Margin | +0.00% |
| Profit Margin | +0.00% |
Source: Nexqual, June 10, 2026 at 12:05 UTC.
Financial Health Score (CBIA)
Nexqual rates CBIA's overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 12:05 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Weak — Gross margin 0%, operating 0% |
| Balance Sheet | Mixed — No data |
| Cash Flow | Mixed — No data |
| Efficiency | Mixed — No data |
Ownership (CBIA)
| Insider Ownership | +65.52% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 2.79B |
Source: Nexqual, June 10, 2026 at 12:05 UTC.
Leadership (CBIA)
CBIA is led by Patrick T. Prendergast, Chairman & CEO, per Nexqual as of June 10, 2026 at 12:05 UTC.
| Chairman & CEO | Patrick T. Prendergast |
|---|---|
| Interim Chief Financial Officer | Benjamin Oates (age 44) |
| COO & Director | Leo J. Prendergast B.A.I., M.A, M.Sc |
| Chief Scientific Officer | Andries J. Lategan B.Pharm, M.Sc |
| President of Oncology Division | Elizabeth Shanahan B.Sc. (Hon) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| NHMD | Nate's Food Co. | USD 0 | ▲ 0% |
| AAPJ | AAP, Inc. | USD 0 | ▲ 0% |
| AIMN | Aimwell Partners Inc. | USD 0.01 | ▲ 0% |
| ECOX | Eco Innovation Group, Inc. | USD 0 | ▼ 25% |
| CGAC | Code Green Apparel Corp. | USD 0 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 12:05 UTC. This page is informational and not investment advice.